DocGo Acquires PTI Health To Expand Proactive Healthcare Offering with Mobile Lab Collection and Mobile Phlebotomy Services
DocGo (NASDAQ: DCGO) has acquired PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company, to expand its healthcare service offerings. The acquisition enhances DocGo's capabilities by incorporating PTI Health's existing partnerships with major labs and their ordering platform integrations.
The strategic move aims to address critical gaps in diagnostic care for underserved populations by providing mobile phlebotomy lab services and at-home testing. DocGo plans to initially expand PTI Health's operations into New York City. PTI Health's services focus on homebound patients and those facing transportation challenges, with their clinicians performing thousands of lab collections annually.
As part of the acquisition, PTI Health President Wayne Meadows will join DocGo as a General Manager. The company plans to leverage this acquisition to drive growth in 2025 and beyond, while expanding their mobile health offerings and strengthening their vertically integrated care model.
DocGo (NASDAQ: DCGO) ha acquisito PTI Health, un'azienda di servizi di prelievo e laboratorio mobile della costa atlantica centrale, per ampliare le sue offerte nel settore sanitario. L'acquisizione potenzia le capacità di DocGo integrando le partnership esistenti di PTI Health con principali laboratori e le loro integrazioni di piattaforme per gli ordini.
DocGo prevede di espandere inizialmente le operazioni di PTI Health a New York City, affrontando importanti lacune nei servizi di laboratorio e diagnostica. PTI Health si specializza nel servire pazienti a domicilio e coloro che hanno difficoltà di trasporto, effettuando migliaia di prelievi di laboratorio annualmente. Tra i loro servizi ci sono prelievi di sangue a domicilio e altre raccolte, facilitando diagnosi e chiusura delle lacune nella cura in collaborazione con fornitori di servizi sanitari.
Come parte dell'acquisizione, il presidente di PTI Health, Wayne Meadows, entrerà in DocGo come Direttore Generale. L'azienda mira a sfruttare questa acquisizione per integrare la propria crescita nel 2025 e oltre, ampliando le sue offerte di salute mobile e rafforzando il loro modello di assistenza integrato verticalmente.
DocGo (NASDAQ: DCGO) ha adquirido PTI Health, una empresa de servicios de recolecta de laboratorio móvil y flebotomía de la costa media atlántica, para expandir su oferta de servicios de salud. La adquisición mejora las capacidades de DocGo al incorporar las asociaciones existentes de PTI Health con importantes laboratorios y sus integraciones de plataformas de pedidos.
DocGo planea expandir inicialmente las operaciones de PTI Health a New York City, abordando brechas críticas en los servicios de laboratorio y diagnóstico. PTI Health se especializa en atender a pacientes confinados en casa y aquellos con problemas de transporte, realizando miles de recolecciones de laboratorio anualmente. Sus servicios incluyen extracciones de sangre a domicilio y otras recolecciones, facilitando diagnósticos y el cierre de brechas de atención en colaboración con proveedores de salud.
Como parte de la adquisición, el presidente de PTI Health, Wayne Meadows, se unirá a DocGo como Gerente General. La empresa pretende aprovechar esta adquisición para complementar su crecimiento en 2025 y más allá, mientras amplía sus ofertas de salud móvil y fortalece su modelo de atención integrada verticalmente.
DocGo (NASDAQ: DCGO)는 의료 서비스 제안을 확장하기 위해 중대서양 모바일 실험실 수집 및 채혈 서비스 회사인 PTI Health를 인수했습니다. 이번 인수로 DocGo는 PTI Health의 주요 실험실과의 기존 파트너십 및 주문 플랫폼 통합을 포함하여 능력을 강화하게 됩니다.
DocGo는 뉴욕시로 PTI Health의 운영을 초기 확장할 계획이며, 실험실 및 진단 서비스의 중요한 공백을 해소하는 데 집중하고 있습니다. PTI Health는 거동이 불편한 환자와 교통 문제를 가진 환자에게 서비스하는 데 전문화되어 있으며, 매년 수천 건의 실험실 수집을 수행합니다. 그들의 서비스에는 외래 환자 가정에서의 혈액 채취 및 기타 수집이 포함되어 있으며, 의료 제공자와 협력하여 진단 및 치료 격차를 해소합니다.
인수의 일환으로 PTI Health의 회장인 Wayne Meadows가 DocGo의 일반 관리자로 합류합니다. 이 회사는 2025년 이후의 성장을 보완하기 위해 이 인수를 활용하고, 모바일 건강 서비스를 확장하며 수직적으로 통합된 의료 모델을 강화하는 것을 목표로 하고 있습니다.
DocGo (NASDAQ: DCGO) a acquis une entreprise de collecte de laboratoire mobile et de services de phlébotomie, PTI Health, située dans la région de l'Atlantique central, pour élargir son offre de services de santé. Cette acquisition renforce les capacités de DocGo en intégrant les partenariats existants de PTI Health avec des laboratoires majeurs et leurs intégrations de plateformes de commande.
DocGo prévoit d'étendre initialement les opérations de PTI Health à New York City, en répondant à des lacunes critiques dans les services de laboratoire et de diagnostic. PTI Health se spécialise dans l'assistance aux patients confinés à domicile et à ceux rencontrant des difficultés de transport, réalisant des milliers de prélèvements de laboratoire chaque année. Leurs services comprennent des prélèvements sanguins à domicile et d'autres collectes, facilitant les diagnostics et la fermeture des gaps dans les soins en collaboration avec les prestataires de soins de santé.
Dans le cadre de l'acquisition, le président de PTI Health, Wayne Meadows, rejoindra DocGo en tant que directeur général. L'entreprise vise à tirer parti de cette acquisition pour compléter sa croissance en 2025 et au-delà, tout en élargissant son offre de santé mobile et en renforçant son modèle de soins intégrés verticalement.
DocGo (NASDAQ: DCGO) hat PTI Health, ein Unternehmen für mobile Laborsammlung und Phlebotomiedienste aus der Mitte der Atlantikküste, erworben, um sein Angebot im Gesundheitsdienstleistungssektor zu erweitern. Die Übernahme verbessert die Fähigkeiten von DocGo, indem sie die bestehenden Partnerschaften von PTI Health mit großen Laboren und deren Integrationen von Bestellplattformen einbezieht.
DocGo plant, die Operationen von PTI Health zunächst nach New York City auszuweiten, um kritische Lücken in den Labor- und Diagnosediensten zu schließen. PTI Health hat sich darauf spezialisiert, Patienten, die im Haus bleiben müssen, sowie Personen mit Transportproblemen zu bedienen und führt jährlich Tausende von Laborsammlungen durch. Zu ihren Dienstleistungen gehören Blutabnahmen und andere Sammlungen zu Hause, die die Diagnostik und Schließung von Versorgungslücken in Zusammenarbeit mit Gesundheitsdienstleistern erleichtern.
Im Rahmen der Übernahme wird der Präsident von PTI Health, Wayne Meadows, als Geschäftsführer zu DocGo stoßen. Das Unternehmen zielt darauf ab, diese Übernahme zu nutzen, um sein Wachstum in 2025 und darüber hinaus zu ergänzen und gleichzeitig seine mobilen Gesundheitsangebote zu erweitern und sein vertikal integriertes Pflegemodell zu stärken.
- Expansion into mobile phlebotomy and lab collection services
- Integration with nation's two largest labs
- Planned expansion into New York City market
- Addition of mobile clinical trials capability
- Strengthening of vertically integrated care model
- None.
Insights
The acquisition of PTI Health marks a strategic expansion of DocGo's mobile healthcare capabilities, positioning the company to capture a larger share of the rapidly growing mobile diagnostics market. The deal offers three key strategic advantages:
First, the integration with the nation's two largest labs provides immediate infrastructure access and established relationships, significantly reducing time-to-market and operational friction. This positions DocGo to rapidly scale PTI's services across their existing footprint.
Second, the expansion into mobile phlebotomy addresses a critical market gap in diagnostic care accessibility. With approximately 7 million Americans considered homebound and many more facing transportation barriers, the addressable market is substantial. The service integration creates a more comprehensive mobile healthcare platform, potentially increasing revenue per patient and improving customer retention.
Third, PTI's expertise in mobile clinical trials opens up a new revenue stream in the lucrative clinical research market, estimated at over $50 billion globally. This diversification reduces dependency on traditional mobile health services and provides exposure to the high-margin research sector.
The immediate expansion into NYC demonstrates intelligent market prioritization, targeting a dense urban area with high healthcare needs and significant transportation challenges. The acquisition's success will likely depend on:
- Successful integration of PTI's ordering platforms with DocGo's existing systems
- Efficient scaling of operations while maintaining service quality
- Effective cross-selling to existing customers
- Retention of key PTI personnel and expertise
While financial terms weren't disclosed, the strategic rationale is compelling. The acquisition enhances DocGo's competitive moat by adding essential diagnostic capabilities to their mobile health platform, potentially accelerating organic growth through service expansion to their existing customer base.
From an operational perspective, this acquisition presents several compelling advantages and key execution considerations. The high NPS score of 86 reported by DocGo suggests strong operational excellence and patient satisfaction, providing a solid foundation for service expansion.
The integration presents three critical operational opportunities:
- Leveraging DocGo's existing mobile health infrastructure to rapidly scale PTI's services, potentially reducing per-visit costs
- Utilizing shared resources across both service lines to improve operational efficiency
- Implementing DocGo's technology platform to optimize routing and scheduling for lab collections
The retention of PTI's leadership, particularly President Wayne Meadows as GM, suggests a focus on maintaining operational continuity and preserving institutional knowledge. This is important for maintaining service quality during the integration phase.
The expansion into NYC serves as a strategic pilot for broader market rollout, allowing DocGo to refine their integrated service model in a challenging urban environment before scaling to other markets. Success in NYC could provide a blueprint for expansion into other major metropolitan areas.
The acquisition enhances DocGo’s offerings by leveraging PTI Health’s existing partnerships and ordering platform integrations with the nation’s two largest labs, and will facilitate PTI Health’s expansion into new markets. Initially, DocGo plans to expand PTI Health’s operations into
“PTI Health has a great team and integrations with the largest laboratory service providers in the US – we are incredibly excited to complete this transaction. By incorporating PTI Health’s mobile lab collection, phlebotomy services and clinical staff, we’re expanding our mobile health offerings and further strengthening our vertically integrated care model to bring diagnostic and primary care services to patients across our footprint,” said Lee Bienstock, CEO of DocGo. “We believe this acquisition is a good example of our ability to expand our offering while leveraging our existing customer base to drive further growth at PTI. We are constantly seeking opportunities to leverage our balance sheet to complement our growth in 2025 and beyond.”
PTI Health specializes in serving patients who are homebound or face transportation challenges, and their clinicians perform thousands of lab collections every year. PTI Health’s experienced mobile phlebotomists perform in-home blood draws and other collections, enabling seamless diagnostics and care gap closure in collaboration with patients’ healthcare providers. PTI also supports mobile clinical trials, adding a new dimension to DocGo’s robust healthcare offering.
As part of the acquisition, PTI Health President Wayne Meadows will join DocGo as a General Manager. “I’m excited to join DocGo and expand on PTI Health’s success bringing vital lab services to patients,” said Meadows. “DocGo delivers a world-class patient experience, as evidenced by their 2024 mobile health Net Promoter Score (NPS) of 86. I look forward to working together to elevate PTI Health’s offering and expand our services across DocGo’s entire US footprint to provide vital healthcare access to even more patients.”
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient’s home or workplace. Together with DocGo’s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the Company’s plans, strategies, outcomes, and prospects, both business and financial, including the Company’s acquisition of PTI Health, the expected benefits of such acquisition, PTI Health’s expansion into new markets and the Company’s acquisition strategy. These statements are based on the beliefs and assumptions of the Company’s management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “might,” “will,” “should,” “could,” “can,” “would,” “design,” “potential,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or the negative of these terms or similar expressions. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond the Company’s control, and which may cause the Company’s actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in the Company’s forward-looking statements, including, but not limited to the following: the Company’s ability to successfully implement its business strategy, including with respect to PTI Health and other acquisitions; the Company’s ability to successfully integrate PTI Health or other acquisitions or realize the benefits of such acquisitions; the Company’s reliance on and ability to maintain its contractual relationships with its healthcare provider partners and clients; the Company’s ability to compete effectively in a highly competitive industry; the Company’s ability to maintain existing contracts; the Company’s reliance on government contracts; the Company’s ability to effectively manage its growth; the Company’s financial performance and future prospects; the Company’s ability to deliver on its business strategies or models, plans and goals; the Company’s ability to expand geographically; the Company’s competitive position and opportunities, including its ability to realize the benefits from its operating model; and other risk factors included in the Company’s filings with the Securities and Exchange Commission. The forward-looking statements made in this press release are based on events or circumstances as of the date on which the statements are made. The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250210820237/en/
Investor Contact
Mike Cole
DocGo
949-444-1341
mike.cole@docgo.com
ir@docgo.com
Source: DocGo Inc.
FAQ
What services will DocGo (DCGO) gain from the PTI Health acquisition?
Where will DocGo (DCGO) first expand PTI Health's operations?
How will the PTI Health acquisition affect DocGo's (DCGO) market presence?
What is DocGo's (DCGO) mobile health Net Promoter Score for 2024?
How will PTI Health integrate into DocGo's (DCGO) leadership structure?
